rs685884

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.1382-54C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.73 in 1,520,384 control chromosomes in the GnomAD database, including 406,547 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 39333 hom., cov: 33)
Exomes 𝑓: 0.73 ( 367214 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.124

Publications

9 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 13-110192967-G-A is Benign according to our data. Variant chr13-110192967-G-A is described in ClinVar as Benign. ClinVar VariationId is 1243583.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.906 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.1382-54C>T intron_variant Intron 22 of 51 ENST00000375820.10 NP_001836.3
COL4A1NM_001303110.2 linkc.1382-54C>T intron_variant Intron 22 of 24 NP_001290039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.1382-54C>T intron_variant Intron 22 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.717
AC:
109031
AN:
152038
Hom.:
39305
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.695
Gnomad AMI
AF:
0.933
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.724
Gnomad EAS
AF:
0.928
Gnomad SAS
AF:
0.795
Gnomad FIN
AF:
0.671
Gnomad MID
AF:
0.731
Gnomad NFE
AF:
0.723
Gnomad OTH
AF:
0.753
GnomAD4 exome
AF:
0.731
AC:
1000270
AN:
1368228
Hom.:
367214
AF XY:
0.733
AC XY:
503035
AN XY:
686446
show subpopulations
African (AFR)
AF:
0.688
AC:
21795
AN:
31662
American (AMR)
AF:
0.653
AC:
29019
AN:
44458
Ashkenazi Jewish (ASJ)
AF:
0.726
AC:
18516
AN:
25516
East Asian (EAS)
AF:
0.943
AC:
37017
AN:
39264
South Asian (SAS)
AF:
0.776
AC:
65416
AN:
84294
European-Finnish (FIN)
AF:
0.674
AC:
35904
AN:
53238
Middle Eastern (MID)
AF:
0.741
AC:
4142
AN:
5588
European-Non Finnish (NFE)
AF:
0.727
AC:
746060
AN:
1026902
Other (OTH)
AF:
0.740
AC:
42401
AN:
57306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
13828
27656
41483
55311
69139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17990
35980
53970
71960
89950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.717
AC:
109113
AN:
152156
Hom.:
39333
Cov.:
33
AF XY:
0.717
AC XY:
53360
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.695
AC:
28854
AN:
41502
American (AMR)
AF:
0.668
AC:
10219
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.724
AC:
2511
AN:
3468
East Asian (EAS)
AF:
0.928
AC:
4799
AN:
5172
South Asian (SAS)
AF:
0.795
AC:
3836
AN:
4824
European-Finnish (FIN)
AF:
0.671
AC:
7093
AN:
10574
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.723
AC:
49143
AN:
68006
Other (OTH)
AF:
0.755
AC:
1595
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1622
3244
4865
6487
8109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.724
Hom.:
65744
Bravo
AF:
0.718
Asia WGS
AF:
0.863
AC:
2995
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.2
DANN
Benign
0.37
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs685884; hg19: chr13-110845314; API